Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
316 | 35223 | 38.6 | 73% |
Classes in level above (level 4) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
0 | 3633673 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//MED |
Classes in level below (level 2) |
ID, lev. below |
Publications | Label for level below |
---|---|---|
876 | 10798 | P GLYCOPROTEIN//MULTIDRUG RESISTANCE//ABCG2 |
1547 | 6824 | GLUTAMATE TRANSPORTER//CYSTINURIA//GLT 1 |
1637 | 6442 | SGLT2 INHIBITOR//DAPAGLIFLOZIN//CANAGLIFLOZIN |
1981 | 5091 | PEPT1//PEPT2//HPEPT1 |
1987 | 5071 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS//JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS//NONMEM |
3517 | 997 | APA HAMSTER//APA HAMSTERS//AMINO ACID LOAD |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | P GLYCOPROTEIN | Author keyword | 1462 | 46% | 7% | 2388 |
2 | MULTIDRUG RESISTANCE | Author keyword | 746 | 34% | 5% | 1822 |
3 | SGLT2 INHIBITOR | Author keyword | 284 | 94% | 0% | 103 |
4 | DAPAGLIFLOZIN | Author keyword | 253 | 92% | 0% | 98 |
5 | GLUTAMATE TRANSPORTER | Author keyword | 220 | 55% | 1% | 277 |
6 | MDR1 | Author keyword | 215 | 45% | 1% | 360 |
7 | ABCG2 | Author keyword | 209 | 55% | 1% | 261 |
8 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | Journal | 209 | 46% | 1% | 338 |
9 | BCRP | Author keyword | 187 | 62% | 1% | 193 |
10 | SGLT2 | Author keyword | 178 | 88% | 0% | 83 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | P GLYCOPROTEIN | 1462 | 46% | 7% | 2388 | Search P+GLYCOPROTEIN | Search P+GLYCOPROTEIN |
2 | MULTIDRUG RESISTANCE | 746 | 34% | 5% | 1822 | Search MULTIDRUG+RESISTANCE | Search MULTIDRUG+RESISTANCE |
3 | SGLT2 INHIBITOR | 284 | 94% | 0% | 103 | Search SGLT2+INHIBITOR | Search SGLT2+INHIBITOR |
4 | DAPAGLIFLOZIN | 253 | 92% | 0% | 98 | Search DAPAGLIFLOZIN | Search DAPAGLIFLOZIN |
5 | GLUTAMATE TRANSPORTER | 220 | 55% | 1% | 277 | Search GLUTAMATE+TRANSPORTER | Search GLUTAMATE+TRANSPORTER |
6 | MDR1 | 215 | 45% | 1% | 360 | Search MDR1 | Search MDR1 |
7 | ABCG2 | 209 | 55% | 1% | 261 | Search ABCG2 | Search ABCG2 |
8 | BCRP | 187 | 62% | 1% | 193 | Search BCRP | Search BCRP |
9 | SGLT2 | 178 | 88% | 0% | 83 | Search SGLT2 | Search SGLT2 |
10 | PEPT1 | 166 | 74% | 0% | 124 | Search PEPT1 | Search PEPT1 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | P GLYCOPROTEIN | 928 | 25% | 9% | 3201 |
2 | MULTIDRUG RESISTANCE | 723 | 23% | 8% | 2766 |
3 | MULTIDRUG RESISTANCE GENE | 511 | 52% | 2% | 697 |
4 | P GLYCOPROTEIN EXPRESSION | 452 | 47% | 2% | 714 |
5 | NEUROTRANSMITTER TRANSPORTERS | 416 | 59% | 1% | 469 |
6 | NA GLUCOSE COTRANSPORTER | 349 | 69% | 1% | 299 |
7 | ORGANIC ANION TRANSPORTER | 314 | 47% | 1% | 501 |
8 | BACTERIAL TRANSPORT PROTEINS | 294 | 72% | 1% | 231 |
9 | CANCER RESISTANCE PROTEIN | 281 | 46% | 1% | 457 |
10 | AMINO ACID TRANSPORTER | 272 | 46% | 1% | 443 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 209 | 46% | 1% | 338 |
2 | JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 163 | 48% | 1% | 250 |
3 | BIOPHARMACEUTICS & DRUG DISPOSITION | 46 | 15% | 1% | 279 |
4 | AAPS JOURNAL | 15 | 12% | 0% | 117 |
5 | DRUG METABOLISM AND PHARMACOKINETICS | 12 | 13% | 0% | 84 |
6 | RENAL PHYSIOLOGY AND BIOCHEMISTRY | 8 | 12% | 0% | 61 |
7 | CONTRIBUTIONS TO NEPHROLOGY | 3 | 14% | 0% | 20 |
8 | AAPS PHARMSCI | 3 | 13% | 0% | 22 |
9 | SELECTIVE CANCER THERAPEUTICS | 1 | 13% | 0% | 8 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Multidrug resistance in cancer: Role of ATP-dependent transporters | 2002 | 2222 | 155 | 70% |
Targeting multidrug resistance in cancer | 2006 | 1240 | 239 | 70% |
BIOCHEMISTRY OF MULTIDRUG-RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER | 1993 | 3128 | 224 | 80% |
Pharmacodynamics, Efficacy and Safety of Sodium-Glucose Co-Transporter Type 2 (SGLT2) Inhibitors for the Treatment of Type 2 Diabetes Mellitus | 2015 | 8 | 134 | 93% |
Biochemical, cellular, and pharmacological aspects of the multidrug transporter | 1999 | 1272 | 159 | 93% |
The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade | 2015 | 10 | 225 | 59% |
A family of drug transporters: The multidrug resistance-associated proteins | 2000 | 1052 | 83 | 87% |
Glutamate uptake | 2001 | 2186 | 1119 | 40% |
THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCE | 1989 | 1998 | 175 | 82% |
ABC multidrug transporters: structure, function and role in chemoresistance | 2008 | 320 | 182 | 84% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BIOSYST PHARMACOL | 55 | 70% | 0.1% | 46 |
2 | PHARMSAKYO KU | 45 | 68% | 0.1% | 39 |
3 | ABT VEGETAT PHYSIOL PATHOPHYSIOL | 42 | 74% | 0.1% | 31 |
4 | PL PHARMACOKINET | 39 | 38% | 0.2% | 80 |
5 | ASAN FDN | 33 | 83% | 0.1% | 19 |
6 | MOL ECOTOXICOL | 29 | 73% | 0.1% | 22 |
7 | PHARMACOKINET DRUG THER Y | 25 | 34% | 0.2% | 60 |
8 | PROV PHARMACOKINET TRANSPORT | 23 | 76% | 0.0% | 16 |
9 | MOL NEUROPHARMACOL GRP | 22 | 58% | 0.1% | 25 |
10 | KYOTO UNIV HOSP | 21 | 31% | 0.2% | 57 |
Related classes at same level (level 3) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000003627 | PRIMARY BILIARY CIRRHOSIS//AUTOIMMUNE HEPATITIS//PRIMARY SCLEROSING CHOLANGITIS |
2 | 0.0000003393 | CYTOCHROME P450//GSTM1//GSTT1 |
3 | 0.0000002907 | AQUAPORIN//HYPONATRAEMIA//ERYPTOSIS |
4 | 0.0000002510 | F 1 ATPASE//ATP SYNTHASE//V ATPASE |
5 | 0.0000002461 | TIGHT JUNCTION//CLAUDIN//OCCLUDIN |
6 | 0.0000002177 | SOLID LIPID NANOPARTICLES//L ASPARAGINASE//NANOSTRUCTURED LIPID CARRIERS |
7 | 0.0000002055 | DIHYDROPYRIMIDINE DEHYDROGENASE//5 FLUOROURACIL//THYMIDINE PHOSPHORYLASE |
8 | 0.0000001696 | KERNICTERUS//HYPERBILIRUBINEMIA//BILIRUBIN |
9 | 0.0000001678 | HEPATIC ENCEPHALOPATHY//KETOGENIC DIET//CARNITINE |
10 | 0.0000001553 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//ANTIMICROBIAL AGENTS AND CHEMOTHERAPY//CHEMOTHERAPY-TOKYO |